Ro Casts Megan Fox as Its ED Pill in First Celebrity Sparks Campaign

Ro launched its first-ever celebrity campaign for Ro Sparks, its compounded erectile dysfunction pill, on Thursday — and the celebrity in question never mentions having ED. Instead, Megan Fox plays the product itself, wearing a red catsuit branded with the Sparks logo and speaking in first person about the medication's ingredients and effects.

The campaign, titled "Megan Fox Is Ro Sparks," breaks sharply from Ro's established celebrity playbook. Previous partners — Serena Williams, Charles Barkley, Trisha Paytas, and Chrissy Metz — all appeared as Ro patients sharing personal experiences, largely tied to the company's GLP-1 weight-loss offerings. Fox cites no studies and no personal history with ED. She simply personifies the pill.

Ro's in-house marketing team made that choice deliberately. The company's consumer research found men are often more receptive to ED marketing when the messenger is a woman. Ro could have cast a woman discussing a partner's ED and framed sexual health as a couple's issue — but the Fox partnership allowed a racier execution. Capitalizing on her persona as a sex symbol was "an idea that wouldn't work with anyone else," the company said in a press release.

What practitioners should watch

For marketers in regulated health categories, the campaign tests how far a DTC brand can push celebrity metaphor before regulatory substance matters. Ro Sparks is not FDA-approved. The medication is a compounded drug combining sildenafil and tadalafil — the active ingredients in Viagra and Cialis, respectively — and dissolves under the tongue for faster onset. Fox's sultry first-person narration describes those ingredients and effects directly, which places the creative in territory the FDA typically polices for prescription-drug advertising.

The media mix signals budget scale. The campaign launched across linear TV, streaming, and paid social simultaneously on Thursday — a broad simultaneous rollout rather than a digital-first test. It extends offline too: a Times Square takeover plus tear-away posters across New York City starting October 5, giving the push an interactive out-of-home layer aimed at earned social amplification.

Separating strategy from speculation

Officially confirmed: the first-celebrity status of the campaign, the research-backed decision to center a woman, the full media plan, and the October 5 out-of-home start date. All of it comes from Ro's own announcement, so treat performance claims accordingly.

Speculative, for now: whether the persona-led approach outperforms Ro's patient-testimonial format. The brand offers no early performance data, and the shift is untested at this scale for the company. What is clear is the strategic logic — ED ads rarely carry cultural heat, and Ro is buying attention with a globally recognized sex symbol rather than borrowing credibility from a patient's story.

The tear-away posters and Times Square takeover suggest Ro expects people to interact with the creative and share it — a bet that offline stunts can generate organic social reach the category usually lacks.

Watch the next earnings or campaign updates from Ro for signals on whether persona-driven creative becomes a repeatable format for the telehealth brand — or a one-off stunt.